Mechanistically, activation of P2RX7 leads to increased production of IL-18 in a NLRP3-dependent manner, which in turn activates NK and CD4+ T cells to produce IFN-γ and consequently increases tumor immunogenicity. Here, P2RX7 is linked to neoplasm.